Ethical Considerations
ORION-5 was conducted in accordance with the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E6 guideline for Good Clinical Practice, which has its origin from the Declaration of Helsinki. The study protocol and all amendments were approved by the independent ethics committee or institutional review board of all participating centers. All patients provided written informed consent.